Combined Chromium With Letrozole Versus Letrozole Only in Induction of Ovulation in Patients With Polycystic Ovary Syndrome

Letrozole and Chromium

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05765305

Enrollment

Registered

2023-03-13

Start date

2018-09-01

Completion date

2019-10-01

Last updated

2023-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic Ovary Syndrome

Brief summary

Combined letrozole with chromium versus letrozole only in induction of ovulation in polycystic ovary syndrome

Detailed description

Randomized controlled trial

Interventions

DRUGLetrozole with chromium

Letrozole versus letrozole with chromium

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 35 Years

Healthy volunteers

Yes

Inclusion criteria

* female patients aged from 18 to 35 years Anovulatory cycles Pcos

Exclusion criteria

* female patients aged more than 35years Male factor of infertility Other factors of infertility than pcos

Design outcomes

Primary

Measure	Time frame	Description
Efficacy of letrozole	12 months	efficacy of letrozole with chromium in improving induction of ovulation

Secondary

Measure	Time frame	Description
Miscarriage rate	12 months	Incidence of OHSS

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026